Regulatory CMC Consulting for Pharmaceutical & Biotechnology Companies
Overcome CMC challenges, strengthen regulatory submissions and reduce avoidable delays on the path to approval.
Polaris Regulatory provides experienced Regulatory CMC strategy, advisory and hands-on support throughout drug development, approval and commercialisation.
We simplify complex issues, bring the right expertise together and help get the critical work done – keeping your programme focused on its next regulatory milestone.
Even with experienced technical teams, complex regulatory challenges can threaten timelines, budgets and approval readiness.
Common challenges include:
Left unresolved, these issues can lead to costly rework, regulatory questions, missed milestones and delayed approval.
Polaris helps you identify what matters, resolve the obstacles and establish a clear route forward.
Getting a programme ready for regulatory approval requires more than technical advice. It requires the right strategy, the right people and the ability to turn decisions into action.
Our approach combines experienced regulatory judgement with practical, independent support.

We review where your programme stands, what needs to be achieved and the technical, regulatory or organisational obstacles threatening progress.
We consider the regulatory requirements, scientific evidence, available options and implications for later development stages.
As an independent specialist, Daniel can work across departmental boundaries, connect technical experts and help resolve competing priorities without becoming caught up in internal structures.
A technically sound submission must also tell a clear, coherent scientific story.
We help translate complex technical information into well-structured regulatory documentation that makes the evidence, decisions and control strategies easier to assess.
Our involvement goes beyond identifying problems and recommending solutions.
We work with your teams to maintain progress, address obstacles, coordinate critical activities and prepare for what comes next.
The outcome: A clearer regulatory pathway, better-coordinated activities, stronger submissions and greater confidence in your next milestone.
Our support is tailored to your programme, development stage and existing internal capabilities.
Develop global Regulatory CMC strategies, assess development risks, anticipate health authority expectations and make better technical and regulatory decisions.
Prepare and review CMC documentation for IND, CTA, NDA, BLA and MAA submissions, support agency interactions and develop responses to health authority questions.
Coordinate critical CMC activities across internal teams, technical specialists and external manufacturing partners to address obstacles and maintain progress.
Access experienced senior Regulatory CMC expertise for strategic guidance, independent oversight or hands-on delivery without immediately expanding your permanent team.
Support the transition to commercial manufacture, post-approval regulatory changes, global market expansion and ongoing product lifecycle requirements.
Experience gained across
Every development milestone creates new regulatory requirements, risks and decisions.
Polaris helps you address today's priorities while preparing for what comes next.

Establish phase-appropriate CMC strategies, strengthen analytical and manufacturing controls, prepare clinical submissions and anticipate late-stage requirements.

Bring together the technical evidence, regulatory documentation and cross-functional activities needed to support submission, regulatory review and commercial readiness.

Navigate manufacturing changes, maintain regulatory compliance, manage commitments and support expansion into new markets and products.
At every stage, two questions guide our approach: What must be achieved now, and what needs to be in place for the next milestone?
We can challenge assumptions, resolve competing views and focus attention on what is best for the programme.
Experience across biologics, small molecules, global regulatory submissions, approvals and lifecycle management.
We simplify difficult issues while maintaining the scientific rigour and regulatory justification they require.
We bring considered judgement, clear communication and a solution-focused approach when timelines are tight and pressure is increasing.
We don't simply provide recommendations. We work alongside your people to help turn decisions into results.
Our philosophy is simple: sound science, straight answers, practical solutions and a commitment to helping clients succeed.
Whether you're facing a complex regulatory challenge, preparing a major submission, responding to health authority questions or planning for commercialisation, Polaris can help.
Let's discuss what's holding your programme back, what needs to be achieved and the most practical route forward.